Pfizer Statement on Xanax

Feb. 17, 2012

View Comments (
)
|
Email
|
Print

    NEWSLETTERS

    TK

    Xanax®, when prescribed and taken as indicated in accordance with the FDA approved product package insert, has a well established safety profile and is a treatment option that has benefitted millions of patients.

    It is imperative that prescribers who are treating patients with Xanax are aware of its risks and communicate them to patients –  before prescribing the product and during the course of the patient’s treatment.

    Under no circumstances does Pfizer condone the misuse or abuse of our products.